Category Archives: Drugs and Health

Brien Roche Law > Blog > Drugs and Health
Drug Testing Labs

Drug labs have been under increasing scrutiny since the New England fiasco in the summer of 2013.  In addition now to the compounding pharmaceutical companies that have been under scrutiny, the labs that test their products are also under scrutiny. … Continue reading

Drug Injury Lawyer – Research

A November 25, 2012 article in The Washington Post raised some serious question as to whether or not drug research can be trusted. As a drug injury lawyer this is something I have known for years. In 2006 the drug maker … Continue reading

Drug Injury From Compounding Pharmacies

As previously indicated on this blog, drug injury from compounding pharmacies such as NECC of  Framingham, Massachusetts are alarming. The fungus that contaminated the pain medication has caused several incidents of meningitis resulting in several deaths.  The fungus causing the disease is very slow to grow … Continue reading

Injury Attorney Comments On Tainted Steroids

Tainted steroids from a compounding pharmacy in Massachusetts have infected potentially hundreds of pain medicine patients reports injury attorney Brien Roche.  The particular drug that was contaminated is methyl-prednisolone acetate.  This is an injectable pain medication that is injected into … Continue reading

Claims Against Pharmacist May Be Barred by the Learned Intermediary Doctrine Reports Injury Attorney

Suppose your pharmacist has filled a prescription for a medication and knows when doing so that you have already been prescribed another medication and that the two medications cannot be used in conjunction with each other, i.e. they are contraindicated.  Do you … Continue reading

Off Label Uses of Drugs

Drug injuries from medications can be attributable to a number of things.It is not uncommon for doctors to prescribe medication for what is called off label uses.  The off-label uses are uses that are not expressly intended as part of the FDA … Continue reading

Failure To Warn- Generic Drugs

Failure to warn claims involving generic drugs took a significant hit on June 23, 2011 with the decision of Pliva, Inc. v. Mensing from the U.S. Supreme Court.  In that decision, the Court diluted the Wyeth decision by concluding that … Continue reading

Medication Errors

Medication errors are on the rise according to the Agency for Healthcare Research and Quality,the lead federal agency charged with improving quality,safety and efficiency of health care for all Americans.  This agency reports that in 2008 1.9 million people became ill … Continue reading

Physician Speaking Fees

Physician speaking fees paid by Merck Pharmaceutical during the year 2010 totalled $20.4 million.  During the year 2010 more than 2,000 U. S. doctors and health care professionals were paid that sum of money to discuss and, in effect, promote … Continue reading

Off-Label Prescription Drug Use

Injury attorney Brien Roche reports that the use of drugs in ways other than described in the FDA-approved label is called “off-label use”. Although it is legal for physicians to prescribe medications for “off-label” uses, it is not legal for … Continue reading